Skip to main content

Technology Transfer

Collaboration with hospitals

Hospital Clínic de Barcelona and CIBERINFEC logo

Study: In vivo toxicological evaluation.

From: Hospital Clínic de Barcelona and CIBERINFEC, Spain

Vall d’Hebron Institut de Recerca logo

Study: In vitro and in vivo efficacy studies of nanovesicles for nucleic acids delivery.

From: Vall d’Hebron Institut de Recerca, Spain

Vall d’Hebron Institut de Recerca logo

Study: In vitro and in vivo efficacy studies of nanoliposomes for enzyme delivery with therapeutic activity.

From: Vall d’Hebron Institut de Recerca, Spain

Institut de Recerca Sant Pau and CIBER-BBN logo

Study: In vivo studies of fluorescent nanovesicles for bioimaging.

From: Institut de Recerca Sant Pau, Spain

Hospital Sant Joan de Déu logo

Study: Characterization by confocal microscopy characterization of nanovesicles.

From: Hospital Sant Joan de Déu, Spain

Hospital Sant Joan de Déu logo

Study: Nucleic acid delivery for muscular dystrophy.

From: Hospital Sant Joan de Déu, Spain

Fundació Institut d'Investigació i Innovació Parc Taulí logo

Study: In vitro toxicological evaluation.

From: Fundació Institut d'Investigació i Innovació Parc Taulí, Spain

Hospital Germans Trias i Pujol logo

Study: Pre-clinical in vivo studies of fluorescent nanovesicles for bioimaging.

From: Hospital Germans Trias i Pujol, Spain

Hospital General Universitario Gregorio and CIBER-BBN logo

Study: Toxicity studies of dendrimers.

From: Hospital General Universitario Gregorio Marañón and CIBER-BBN, Spain

Charité - Universitätsmedezin Berlins logo

Study: In vitro and ex vivo evaluation of biomaterials.

From: Charité - Universitätsmedezin Berlin, Germany

Charité - Universitätsmedezin Berlins logo

Study: Development of nanopharmaceutical products for Lysosomal Storage Diseases.

From: Newcastle University upon Tyne, UK